Skip to main content
Mendel Tuchman, MD, Medical Genetics, Washington, DC

MendelTuchmanMD

Medical Genetics Washington, DC

Clinical Biochemical Genetics, Clinical Genetics

Professor, Pediatrics, G Washington University School of Medicine & Hlth Sci

Are you Dr. Tuchman?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 34 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    111 Michigan Ave Nw
    Washington, DC 20010
    Phone+1 202-884-2187

Summary

  • Dr. Mendel Tuchman, MD is a medical geneticist in Washington, District of Columbia. He is currently licensed to practice medicine in District of Columbia, Maryland, and Virginia. He is a Professor at G Washington University School of Medicine & Hlth Sci.

Education & Training

  • University of Minnesota
    University of MinnesotaResidency, Pediatrics, 1980 - 1985
  • Tel Aviv University Sackler
    Tel Aviv University SacklerClass of 1979
  • University of Minnesota
    University of MinnesotaFellowship, Medical Genetics and Genomics

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2001 - 2025
  • VA State Medical License
    VA State Medical License 2001 - 2022
  • DC State Medical License
    DC State Medical License 1999 - 2018
  • MN State Medical License
    MN State Medical License 1981 - 2014
  • American Board of Pediatrics Pediatrics

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • RECORDATI RARE DISEASES: CARBAGLU® (Carglumic Acid) Tablets 200mg Receives U.S. FDA Approval for a New Indication to Treat Acute Hyperammonemia Associated with Propionic Acidemia and Methylmalonic Acidemia
    RECORDATI RARE DISEASES: CARBAGLU® (Carglumic Acid) Tablets 200mg Receives U.S. FDA Approval for a New Indication to Treat Acute Hyperammonemia Associated with Propionic Acidemia and Methylmalonic AcidemiaJanuary 26th, 2021
  • $5 Million in Federal Funding to Help Patients with Urea Cycle Disorders
    $5 Million in Federal Funding to Help Patients with Urea Cycle DisordersOctober 24th, 2019